Tuesday, May 26, 2026
Today's Edition

EveryNews

Stories that matter, signal over noise

Business

Over-the-Counter Medicines at Gas Stations: First Licenses and the Impact on Access to Medicines

The Prime Minister said that starting next week over-the-counter medicines will be available at gas stations — 15 licenses have already been issued and another 43 applications are under review. We examine who stands to gain and who risks losing control over prices and safety.

Tetiana Suchkova-Ladik

By Tetiana Suchkova-Ladik

March 18, 2026 · 2 min read

Over-the-Counter Medicines at Gas Stations: First Licenses and the Impact on Access to Medicines
Фото: depositphotos.com

Why this matters now

The decision to allow the sale of over-the-counter (OTC) medicines at gas station chains changes the map of access to basic healthcare. At a time when logistics and mobility are a matter of safety and economy for many communities, this can ease life for hundreds of thousands of people, especially in regions with limited infrastructure.

What was announced

Prime Minister Yuliia Svyrydenko, after meeting with Health Minister Viktor Liashko, announced that from next week over-the-counter medicines will be available for purchase at gas stations. As of today, 15 licenses have been issued and another 43 applications are under review.

"Control is ensured by the State Medicines Service"

— Yuliia Svyrydenko, Prime Minister

Control and safety

Officially, responsibility for control is placed on the State Service for Medicines and Drug Control — a key argument in favor of a safe rollout. However, practical implementation means new requirements for storage, record-keeping and staff at gas stations, as well as potential pressure on the traditional pharmacy network.

Energy resilience of healthcare

During the same meeting they also discussed energy autonomy of medical facilities as part of regional resilience plans. According to the prime minister, more than 250 facilities are already equipped with solar panels, and a further 300 are planned to be equipped by the end of the year. A pilot project to install batteries for hospitals is being prepared, prioritizing front-line regions.

"More than 250 facilities already have solar panels, another 300 will be equipped by the end of the year. We are also preparing a pilot to install batteries for all hospitals, first and foremost in front-line regions"

— Yuliia Svyrydenko, Prime Minister

Economic and market consequences

Given that the Cabinet of Ministers previously allowed the sale of OTC drugs in gas station premises (the decision is dated December 2025) and in February introduced a mechanism to increase price transparency for medicines, the key question is how this will affect prices and availability. An investigation by LIGA.net has already contacted operators (OKKO, Ukrnafta, UPG) and pharmacy chains (Podorozhnik, 911, liki.ua) to assess the impact on the business model of pharmacies and manufacturers.

What this means for the reader

In short: more access points for basic medicines can be beneficial for the population, but success depends on quality control, price transparency and compliance with rules by gas stations. For patients it's a chance to obtain needed medicines faster; for pharmacies it's a competitive challenge; for the state it's a test of the system's compliance with safety standards.

Conclusion — what to watch next

Keep an eye on three things: 1) how the State Medicines Service implements control and inspections; 2) whether OTC prices change in the coming months; 3) whether energy initiatives adhere to sustainability plans for hospitals in front-line areas. These are simple indicators that will show whether the decision truly serves safety and access, and not just temporary convenience for the market.

Related

Latest

Business

EU Against Google: Why the Latest Fine Could Change More Than Previous Ones

# European Regulators Target Google Again — This Time Over Digital Markets Act Violations. What's Behind the Accusations and Why It Matters Beyond the Corporation European regulators have renewed their scrutiny of Google, this time focusing on alleged violations of the Digital Markets Act. The charges underscore Brussels' increasingly aggressive stance on big tech monopolies and what officials say are anticompetitive practices. The accusations center on how Google leverages its dominance across multiple digital services — from search to advertising to mobile platforms — to disadvantage competitors. Regulators claim the company is using its market power in ways that stifle innovation and limit consumer choice. The case carries significance far beyond Google itself. It signals how the EU is attempting to enforce its landmark Digital Markets Act, legislation designed to curb the gatekeeping power of tech giants. A potential penalty could set precedent for how other large technology companies face similar scrutiny. For consumers and smaller tech firms, the outcome could reshape the digital landscape by creating more room for competition. For Google, fines and operational restrictions could fundamentally alter its business model in Europe, the world's most stringent regulatory market. The case also reflects a broader geopolitical divide, with the EU pursuing a regulatory approach that contrasts sharply with the lighter-touch oversight favored in the United States.

May 26, 2026